Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia Publisher



Pakzad R1 ; Mohammadianhafshejani A2 ; Ghoncheh M3 ; Pakzad I4 ; Salehiniya H1, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Department of Microbiology, Medical School, Ilam University of Medical Sciences, Ilam, Iran
  5. 5. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Prostate International Published:2015


Abstract

Purpose Prostate cancer is a common cancer in men in the world. It is rapidly increasing. This study investigated the incidence and mortality of prostate cancer and the relationship with the Human Development Index (HDI) and its dimensions in Asia in 2012. Methods The study was conducted based on data from the world data of cancer and the World Bank (including the HDI and its components). The standardized incidence and mortality rates of prostate cancer were calculated for Asian countries. The correlation between incidence, mortality rates, and the HDI and its components were assessed with the use of the correlation test, using SPSS software. Results There was a total of 191,054 incidences and 81,229 death were recorded in Asian countries in 2012. Among the Asian countries, the five countries with the highest standardized incidence rates of prostate cancer were Israel, Turkey, Lebanon, Singapore, and Japan, and the five countries with the highest standardized mortality rates were Turkey, Lebanon, Timor-Leste, Armenia, and the Philippines. The correlation between standardized incidence rate of prostate cancer and the HDI was 0.604 (P ≤ 0.001), with life expectancy at birth 0.529 (P = 0.002), with mean years of schooling 0.427 (P = 0.001), and with level of income per each person of the population 0.349 (P = 0.013). Also, between the standardized mortality rate and the HDI, it was 0.228 (P = 0.127). Conclusions A significant and positive correlation was observed between the standardized incidence rate of prostate cancer, and the HDI and its dimensions, such as life expectancy at birth, mean years of schooling, and income level of the population per each person of population. However, there was no significant correlation between the standardized mortality rate, and the HDI and its dimensions. Copyright © 2015 Asian Pacific Prostate Society, Published by Elsevier.
Related Docs
View other Related Docs
1. Incidence and Mortality of Breast Cancer and Their Relationship to Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
2. Incidence and Mortality of Bladder Cancer and Their Relationship With Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
3. The Incidence and Mortality of Lung Cancer and Their Relationship to Development in Asia, Translational Lung Cancer Research (2015)
4. The Incidence and Mortality of Ovarian Cancer and Their Relationship With the Human Development Index in Asia, ecancermedicalscience (2016)
5. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
6. Investigation of Prostate Disorders in 614 Patients Attended Alzahra/Urology Ward Between the Years 2013 to 2015 in Isfahan, International Journal of Pharmaceutical and Clinical Research (2016)
7. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
8. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
Experts (# of related papers)
View all Related Experts
Zahra Tolou-Ghamari (4)
Mohammad Yazdani (3)
Other Related Docs
9. Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015, International Journal of Preventive Medicine (2012)
10. International Epidemiology of Liver Cancer: Geographical Distribution, Secular Trends and Predicting the Future, Journal of Preventive Medicine and Hygiene (2020)
11. The Risk Factors of Prostate Cancer: A Multicentric Case-Control Study in Iran, Asian Pacific Journal of Cancer Prevention (2007)
12. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
13. Investigating the Incidence of Prostate Cancer in Iran 2005-2008 Using Bayesian Spatial Ecological Regression Models, Asian Pacific Journal of Cancer Prevention (2015)
14. Igf1 Ca-Repeat Polymorphism and Prostate Cancer Development in Isfahan Province of Iran, Journal of Kerman University of Medical Sciences (2018)
15. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
16. Determination of Prostate Cancer Risk Factors in Isfahan, Iran: A Case-Control Study., Medicinski arhiv (2012)
17. Relation Between Serum Level of Total Psa and Free Psa/Total Psa Ratio With Grade of Prostate Cancer, Journal of Isfahan Medical School (2013)
18. Association Between Calcium Intake and Prostate Neoplasm; a Systematic Review and Meta-Analysis, Journal of Nephropathology (2024)
19. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
20. Diagnostic Utility of A-Methylacyl Coa Racemase in Prostate Cancer of the Iranian Population, Journal of Research in Medical Sciences (2021)
21. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
22. Association Between Nut Consumption and Prostate Cancer Risk in Adults: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies, Nutrition, Metabolism and Cardiovascular Diseases (2023)
23. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data From a Cancer Specific Hospital in Isfahan, International Journal of Preventive Medicine (2013)
24. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
25. The Frequency of Exon 2 Mutations of Klf6 Tumor Suppressor Gene in Prostate Cancer Specimens, Journal of Isfahan Medical School (2012)
26. Dietary Intake and Biomarkers of Linoleic Acid and Risk of Prostate Cancer in Men: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies, Critical Reviews in Food Science and Nutrition (2024)
27. Regional Disparities in Cancer Survival in Iran: Insight From a National Surveillance of Cancer Survival in Iran (Irancansurv), Cancer Epidemiology (2023)
28. Incidence, Prevalence, and Mortality Rate of Gastrointestinal Cancer in Isfahan, Iran: Application of the Miamod Method, Asian Pacific Journal of Cancer Prevention (2016)
29. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
30. Glutathione S-Transferase Mu Gene Variants and Colorectal Cancer Development - Use of Sequence-Specific Probes for an Iranian Population, Asian Pacific Journal of Cancer Prevention (2011)
31. Biomarkers for Evaluation of Prostate Cancer Prognosis, Asian Pacific Journal of Cancer Prevention (2015)
32. Incidence and Risk Factors of Pancreatic Cancer During 15 Years Follow-Up in the Golestan Cohort Study in Iran, PLoS ONE (2024)
33. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)
34. Preliminary Study of Prevalence for Bladder Cancer in Isfahan Province, Iran, Arab Journal of Urology (2018)
35. The Incidence and Mortality of Esophageal Cancer and Their Relationship to Development in Asia, Annals of Translational Medicine (2016)
36. Cancers of Urinary System, Prevalence, Demographic, Urologiia (2019)
37. New Gleason Grade Groups; Epidemiologic Data From Isfahan, Iran Based on the New Classification, Immunopathologia Persa (2022)
38. The Association Between Dietary Diversity Score and Risk of Prostate Cancer: (A Case-Control Study), Nutrition and Cancer (2022)
39. Cancers of Urinary System; Prevalence, Demographic, Jundishapur Journal of Chronic Disease Care (2019)
40. Effect of Androgen Deprivation Therapy on Cardiovascular Risk Factors in Prostate Cancer, Journal of Research in Medical Sciences (2013)
41. Bladder Cancer in Iran: Geographical Distribution and Risk Factors, International Journal of Cancer Management (2017)
42. Incidental Prostate Cancer: A 10-Year Review of a Tertiary Center, Tehran, Iran, Research and Reports in Urology (2018)
43. Recent Patterns of Bladder Cancer Incidence and Mortality: A Global Overview, World Cancer Research Journal (2020)
44. The Study of Taaaa Repeat Polymorphism in P53 Gene and Its Association With Prostate Cancer, Journal of Isfahan Medical School (2016)